Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126600551 | 12660055 | 1 | I | 20160517 | 20160805 | 20160817 | 20160817 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51506BP | BOEHRINGER INGELHEIM | 62.90 | YR | F | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126600551 | 12660055 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 300 MG | 21698 | 150 | MG | TABLET | |||||||
126600551 | 12660055 | 2 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 21698 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126600551 | 12660055 | 1 | Dyspepsia |
126600551 | 12660055 | 2 | Dyspepsia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126600551 | 12660055 | Drug ineffective | |
126600551 | 12660055 | Dyspepsia | |
126600551 | 12660055 | Meniscus injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126600551 | 12660055 | 1 | 2012 | 0 |